Fredag 27 December | 02:25:17 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2026-02-06 08:30 Bokslutskommuniké 2025
2025-10-24 08:30 Kvartalsrapport 2025-Q3
2025-07-11 08:30 Kvartalsrapport 2025-Q2
2025-04-25 08:30 Kvartalsrapport 2025-Q1
2025-04-03 N/A Årsstämma
2025-02-05 08:30 Bokslutskommuniké 2024
2024-10-25 - Kvartalsrapport 2024-Q3
2024-07-12 - Kvartalsrapport 2024-Q2
2024-05-22 - Extra Bolagsstämma 2024
2024-04-24 - Kvartalsrapport 2024-Q1
2024-04-10 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2024-04-09 - Årsstämma
2024-02-09 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2023-05-02 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-04-29 - Kvartalsrapport 2022-Q1
2022-04-05 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2022-04-04 - Årsstämma
2022-02-11 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-05-11 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2021-05-10 - Årsstämma
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-19 - Bokslutskommuniké 2020
2020-10-23 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-04-24 - Kvartalsrapport 2020-Q1
2020-04-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2020-04-02 - Årsstämma
2020-03-10 - Extra Bolagsstämma 2020
2020-02-07 - Bokslutskommuniké 2019
2019-10-25 - Kvartalsrapport 2019-Q3
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-07 - Extra Bolagsstämma 2019
2019-04-26 - Kvartalsrapport 2019-Q1
2019-04-09 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2019-04-08 - Årsstämma
2019-02-08 - Bokslutskommuniké 2018
2018-10-26 - Kvartalsrapport 2018-Q3
2018-07-20 - Kvartalsrapport 2018-Q2
2018-04-27 - Kvartalsrapport 2018-Q1
2018-04-10 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2018-04-09 - Årsstämma
2018-02-23 - Bokslutskommuniké 2017
2017-11-10 - Kvartalsrapport 2017-Q3
2017-08-18 - Kvartalsrapport 2017-Q2
2017-05-23 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2017-05-22 - Årsstämma
2017-05-15 - Kvartalsrapport 2017-Q1
2017-02-24 - Bokslutskommuniké 2016
2017-02-20 - Extra Bolagsstämma 2017
2016-11-04 - Kvartalsrapport 2016-Q3
2016-08-19 - Kvartalsrapport 2016-Q2
2016-05-25 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2016-05-24 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-23 - Bokslutskommuniké 2015
2015-11-06 - Kvartalsrapport 2015-Q3
2015-08-21 - Kvartalsrapport 2015-Q2
2015-05-07 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2015-05-06 - Årsstämma
2015-05-06 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-22 - Kvartalsrapport 2014-Q2
2014-06-04 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2014-06-03 - Årsstämma
2014-05-09 - Kvartalsrapport 2014-Q1
2014-02-21 - Bokslutskommuniké 2013
2014-02-12 - Extra Bolagsstämma 2014
2013-11-06 - Kvartalsrapport 2013-Q3
2013-08-22 - Kvartalsrapport 2013-Q2
2013-05-03 - Kvartalsrapport 2013-Q1
2013-05-03 - X-dag ordinarie utdelning EPIS B 0.00 SEK
2013-05-02 - Årsstämma
2013-04-03 - Extra Bolagsstämma 2013
2013-02-21 - Bokslutskommuniké 2012
2012-11-21 - Kvartalsrapport 2012-Q3
2012-08-22 - Kvartalsrapport 2012-Q2
2012-06-04 - Årsstämma
2012-05-04 - Kvartalsrapport 2012-Q1
2012-02-21 - Bokslutskommuniké 2011
2011-11-21 - Kvartalsrapport 2011-Q3
2011-08-22 - Kvartalsrapport 2011-Q2
2011-07-20 - Split EPIS B 6:1
2011-06-30 - Årsstämma
2011-05-21 - Kvartalsrapport 2011-Q1
2011-05-13 - Extra Bolagsstämma 2011
2011-05-02 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010
2010-08-30 - Extra Bolagsstämma 2010

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Episurf Medical är ett verksamt inom medicinteknik. Bolaget driver forskning och utveckling av produkter som används för behandling av broskskador. Episurfs primära fokus är riktat mot återhämtning av knäleder men bolagets implantat kan även appliceras på övriga leder. Episurf Medical befinner sig i preklinisk verifieringsfas och har sitt huvudkontor i Stockholm.
2024-04-09 16:30:00

Episurf Medical AB (publ) ("Episurf" or the "Company") held its Annual General Meeting (the "Meeting") on Tuesday, 9 April 2024 in Stockholm.

The income statements and the balance sheets for the Company and the group were approved and the Board of Directors and the CEO were discharged from liability for the financial year 2023.

The Meeting resolved, in accordance with the proposal of the Board of Directors, that the Company shall not pay dividends for the financial year 2023.

The Meeting resolved to approve the remuneration report for the financial year 2023.

In accordance with the proposal by the Nomination Committee, Annette Brodin Rampe, Ulf Grunander, Christian Krüeger, Leif Ryd and Laura Shunk were re-elected as members of the Board of Directors and Jess Lonner was elected as a new member of the Board of Directors. Also in accordance with the proposal by the Nomination Committee, Ulf Grunander was re-elected as Chairman of the Board of Directors.

In accordance with the proposal by the Nomination Committee, the Meeting resolved that total fees of SEK 1,425,000 (SEK 1,225,000) are to be paid to the Board of Directors, of which SEK 400,000 (SEK 400,000) is to be paid to the Chairman of the Board of Directors, SEK 200,000 (SEK 200,000) is to be paid to each of the other board members and SEK 25,000 (SEK 25,000) is to be paid to the Chairman of the Board of Directors' Audit Committee.

In accordance with the proposal by the Nomination Committee, the registered accounting firm Öhrlings PricewaterhouseCoopers AB was elected as the auditor of the Company, with the authorised public accountant Tobias Stråhle as the auditor in charge. The auditors' fee shall be paid in accordance with approved invoice.

The Meeting approved the Nomination Committee's proposal on the nomination procedure and instruction for the Nomination Committee for the Annual General Meeting 2025.

The Meeting approved the Board of Directors' proposal regarding guidelines for remuneration to the senior management.

Finally, the Meeting resolved, in accordance with the proposal of the Board of Directors, on an issue authorisation for the Board of Directors.

Episurf Medical AB (publ)

The Board of Directors